Osaic Holdings’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $474K | Buy |
4,486
+2,321
| +107% | +$245K | ﹤0.01% | 2867 |
|
|
2025
Q1 | $228K | Buy |
2,165
+125
| +6% | +$13.1K | ﹤0.01% | 3517 |
|
|
2024
Q4 | $219K | Sell |
2,040
-1,786
| -47% | -$191K | ﹤0.01% | 3512 |
|
|
2024
Q3 | $383K | Buy |
3,826
+467
| +14% | +$46.7K | ﹤0.01% | 3114 |
|
|
2024
Q2 | $283K | Buy |
3,359
+2,722
| +427% | +$229K | ﹤0.01% | 3265 |
|
|
2024
Q1 | $46.6K | Sell |
637
-662
| -51% | -$48.4K | ﹤0.01% | 4787 |
|
|
2023
Q4 | $92.3K | Sell |
1,299
-244
| -16% | -$17.3K | ﹤0.01% | 4484 |
|
|
2023
Q3 | $92.4K | Buy |
1,543
+191
| +14% | +$11.4K | ﹤0.01% | 4566 |
|
|
2023
Q2 | $97.5K | Buy |
1,352
+13
| +1% | +$937 | ﹤0.01% | 4454 |
|
|
2023
Q1 | $98.5K | Sell |
1,339
-30
| -2% | -$2.21K | ﹤0.01% | 4462 |
|
|
2022
Q4 | $92.5K | Sell |
1,369
-957
| -41% | -$64.7K | ﹤0.01% | 4497 |
|
|
2022
Q3 | $125K | Buy |
2,326
+48
| +2% | +$2.58K | ﹤0.01% | 4171 |
|
|
2022
Q2 | $127K | Buy |
2,278
+128
| +6% | +$7.14K | ﹤0.01% | 4204 |
|
|
2022
Q1 | $151K | Buy |
2,150
+206
| +11% | +$14.5K | ﹤0.01% | 4254 |
|
|
2021
Q4 | $186K | Sell |
1,944
-81
| -4% | -$7.75K | ﹤0.01% | 4009 |
|
|
2021
Q3 | $175K | Sell |
2,025
-123
| -6% | -$10.6K | ﹤0.01% | 4030 |
|
|
2021
Q2 | $175K | Sell |
2,148
-731
| -25% | -$59.6K | ﹤0.01% | 3974 |
|
|
2021
Q1 | $273K | Sell |
2,879
-906
| -24% | -$85.9K | ﹤0.01% | 3463 |
|
|
2020
Q4 | $236K | Sell |
3,785
-1,716
| -31% | -$107K | ﹤0.01% | 3323 |
|
|
2020
Q3 | $332K | Sell |
5,501
-331
| -6% | -$20K | ﹤0.01% | 2801 |
|
|
2020
Q2 | $407K | Buy |
5,832
+124
| +2% | +$8.65K | ﹤0.01% | 2520 |
|
|
2020
Q1 | $257K | Buy |
+5,708
| New | +$257K | ﹤0.01% | 2665 |
|